The CTA Teardown: A Clause-by-Clause Negotiation Checklist

Most CTA advice is written by lawyers for lawyers. This is not that. This is an operator’s checklist: the clauses in the order you will meet them, the position to take on each, and the reason the position holds.

It comes from 14 years of negotiating these agreements for sites, and from the sponsor-side years where I watched sites skip every position on this list.

Work with counsel on the legal clauses. Nothing here is legal advice. But do not hand the whole document to counsel and check out. The financial clauses are business decisions, and they are yours.

Parties and definitions

Check who the paying party is. Sponsor-signed and CRO-signed agreements behave differently when payments slow down. If the CRO signs, ask what happens to money owed if the sponsor-CRO relationship ends.

Check assignment. Can the sponsor assign the agreement to another company without your consent? Studies get sold. Your payment terms should survive the sale.

Term and termination

Termination for convenience. Expect the sponsor to keep this right. Your job is pricing it, not deleting it. The position: payment for all work performed through the notice date, patient follow-up costs for enrolled subjects, and defined close-out payment.

Startup protection. The startup fee should be fully earned on execution. A study cancelled before first patient still consumed your regulatory, training, and setup hours.

Notice period. Longer is better for staffing. Thirty days is thin for a site holding coordinator capacity against the study.

Payment terms

This is the money section. Read it twice.

• Invoicing cycle. Monthly beats quarterly. Automatic payment against completed visits beats invoice-and-wait.
• Net terms. Every extra net day is your site financing the sponsor. Push down.
• Payment trigger. Visit completion should trigger payment. Monitoring verification as a payment gate means their staffing schedule controls your cash flow.
• Holdback. First position: none. Fallback: small, with a defined release event and a hard date.
• Final payment. Tie it to a defined close-out event with a day count. “Following study completion” with no date is not a term.
• Pass-through costs. IRB fees, advertising, equipment. Confirm they are paid at cost, promptly, without netting against visit payments.

The budget exhibit

The budget rides inside the CTA, and the CTA’s language controls it.

• Amendment re-opener. Any protocol amendment that changes the schedule of assessments triggers a budget amendment before implementation. This sentence pays for the whole negotiation.
• Screen failures. Reimbursed per screen failure at a stated rate. Check the cap against the protocol’s real eligibility funnel, not against optimism.
• Invoiceables exhibit. Unscheduled visits, re-consents, extended monitoring visits, records requests, safety reporting work, storage. Listed, with rates. Strike “inclusive of all site costs” wherever it appears. The seven most expensive versions of this problem are in the red flags teardown.
• Overhead. Applied to the full budget, including invoiceables, at your stated rate.

Confidentiality

Duration. Confidentiality obligations that survive forever are a compliance burden with no revenue attached. Ask for a defined survival period.

Carve-outs. Information you already knew, information that becomes public, information you develop independently. Standard carve-outs. Confirm they are present.

Return or destroy. Watch for clauses requiring certified destruction of every copy. Your regulatory retention obligations conflict with that. The clause should defer to retention requirements.

Publication and results

Sites rarely publish alone, but the clause still matters. The sponsor review window before any site publication should have a defined length. Indefinite review is a veto dressed as a process. If your PI cares about publication, this clause is where their academic life gets negotiated.

Intellectual property

The sponsor owns study data and study-specific inventions. Expected. The position to hold: your site keeps its pre-existing IP, its operational know-how, and its general knowledge. A clause claiming everything your staff learns during the study is overreach. Narrow it to inventions arising directly from the protocol.

Indemnification and subject injury

The clause pair with the largest downside on the page.

• Mutuality. The sponsor indemnifies the site for protocol-driven harm and product liability. The site indemnifies for its own negligence. One-way clauses are a red flag, not a norm.
• Subject injury. The sponsor pays reasonable medical costs for protocol-related injury. Watch for language routing costs through the subject’s or the site’s insurance first, or requiring sponsor pre-approval of care.
• Insurance requirements. Check the coverage amounts the CTA demands against the policy you actually hold, before signing, not after an event.

Get counsel on this section. The business case is simple: one bad event under a bad clause outweighs every fee you saved skipping the review.

Records, monitoring, and audits

• Retention. Regulatory retention runs for years after study close. If the sponsor requires retention beyond your standard practice, storage becomes an invoiceable with an annual rate.
• Monitoring access. Notice periods for monitor visits protect your clinic schedule. Same-week demands are a staffing cost.
• Audit support. Sponsor and regulatory audits consume coordinator days. Sponsor-caused audits beyond routine monitoring belong on the invoiceables list.

Governing law and dispute resolution

You will not move a large sponsor off its preferred governing law. Spend your capital elsewhere. Do read the venue clause once: defending a dispute in a distant jurisdiction has a real price, and knowing it is part of pricing the deal.

The triage read, when there is no time

Sometimes the CTA lands on Thursday and the sponsor wants signature Monday. You should push back on that timeline, and you should also have a triage protocol for when pushing back fails.

Fifteen minutes, four stops. One: the payment section. Cycle, net terms, trigger, holdback. Two: termination. What happens to money if the study dies early. Three: the amendment language. Does changed work reopen the budget or not. Four: the subject-injury clause. Who pays when a patient is harmed.

Those four stops cover the outcomes that can genuinely hurt your site. Everything else on this page matters, but those four decide whether a bad month becomes a bad year. If any of the four fails the read, the Monday signature waits. A sponsor that walks away because you took three extra days on patient-injury language was not a sponsor you could afford.

How to run the teardown in practice

The checklist only works if it survives contact with a busy clinic. Here is the operating procedure that makes it stick.

Two passes, two readers. First pass is yours, and it is purely financial. Read only for the money clauses above: payment, budget mechanics, termination, retention costs. Mark everything. Second pass is counsel’s, and it is legal: indemnification, subject injury, IP, confidentiality. Two focused reads beat one exhausted one, and they can happen in parallel.

One tracking sheet per agreement. Columns: clause, their language, your position, status, owner. Every draft that comes back gets checked against the sheet. Sponsors reissue documents, and positions you won in draft two have a way of quietly reverting in draft four. The sheet catches reversions in minutes. Memory does not catch them at all.

Time-box the internal review. Give the financial pass a deadline measured in days, not weeks. Startup timelines die in internal queues as often as they die in sponsor queues. A CTA sitting unread on your own desk costs you the same enrollment window as one sitting on theirs.

Never negotiate clause by clause in serial. Collect every position into one consolidated response. Serial negotiation lets the other side trade you the same concession twice. A consolidated redline forces the whole package onto the table at once, where the trades are visible.

Close with a signature-ready summary. Before the final draft circulates for signature, one page: what changed from their template, what you accepted as-is, what it means operationally. Your PI and your coordinator lead should be able to read it in five minutes. The people delivering the study deserve to know what deal they are delivering under.

The one-page version

Before signature, confirm you can answer yes to each:

1. Monthly payment cycle with defined net terms?
2. Payment triggered by completed work, not monitoring review?
3. Holdback absent, or small with a dated release?
4. Startup fee fully earned at execution?
5. Termination clause pays wind-down, follow-up, and close-out?
6. Amendment re-opener for any change to the schedule of assessments?
7. Screen failures reimbursed at a rate that matches the eligibility funnel?
8. Invoiceables listed in an exhibit with rates?
9. Overhead at your rate, applied to the full budget?
10. Indemnification mutual, subject-injury clause clean, insurance limits checked?
11. Retention, monitoring, and audit costs accounted for?
12. Counsel has read the legal clauses?

Twelve yes answers is a signable document. Anything less is a document that still owes you money.

For the budget mechanics behind questions six through nine, the full method is in the fair trial budget guide.

And if you would rather have the person who wrote this checklist run the whole negotiation, that is what I do for research sites.